322 related articles for article (PubMed ID: 17324946)
1. Dual blockade of aldosterone and angiotensin II additively suppresses TGF-beta and NADPH oxidase in the hypertensive kidney.
Onozato ML; Tojo A; Kobayashi N; Goto A; Matsuoka H; Fujita T
Nephrol Dial Transplant; 2007 May; 22(5):1314-22. PubMed ID: 17324946
[TBL] [Abstract][Full Text] [Related]
2. Effects of enalapril, tempol, and eplerenone on salt-induced hypertension in dahl salt-sensitive rats.
Bayorh MA; Mann G; Walton M; Eatman D
Clin Exp Hypertens; 2006 Feb; 28(2):121-32. PubMed ID: 16546838
[TBL] [Abstract][Full Text] [Related]
3. Additive amelioration of oxidative stress and cardiac function by combined mineralocorticoid and angiotensin receptor blockers in postinfarct failing hearts.
Noda K; Kobara M; Hamada J; Yoshifuji Y; Shiraishi T; Tanaka T; Wang J; Toba H; Nakata T
J Cardiovasc Pharmacol; 2012 Aug; 60(2):140-9. PubMed ID: 22549451
[TBL] [Abstract][Full Text] [Related]
4. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
[TBL] [Abstract][Full Text] [Related]
5. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
[TBL] [Abstract][Full Text] [Related]
6. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone.
Keidar S; Kaplan M; Pavlotzky E; Coleman R; Hayek T; Hamoud S; Aviram M
Circulation; 2004 May; 109(18):2213-20. PubMed ID: 15123520
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II and oxidative stress in Dahl Salt-sensitive rat with heart failure.
Tojo A; Onozato ML; Kobayashi N; Goto A; Matsuoka H; Fujita T
Hypertension; 2002 Dec; 40(6):834-9. PubMed ID: 12468566
[TBL] [Abstract][Full Text] [Related]
8. Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1.
Shibata S; Nagase M; Yoshida S; Kawachi H; Fujita T
Hypertension; 2007 Feb; 49(2):355-64. PubMed ID: 17200434
[TBL] [Abstract][Full Text] [Related]
9. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.
Nagata K; Obata K; Xu J; Ichihara S; Noda A; Kimata H; Kato T; Izawa H; Murohara T; Yokota M
Hypertension; 2006 Apr; 47(4):656-64. PubMed ID: 16505208
[TBL] [Abstract][Full Text] [Related]
10. Interactions of NADPH oxidase, renin-angiotensin-aldosterone system and reactive oxygen species in mequindox-mediated aldosterone secretion in Wistar rats.
Huang XJ; Wang X; Ihsan A; Liu Q; Xue XJ; Su SJ; Yang CH; Zhou W; Yuan ZH
Toxicol Lett; 2010 Oct; 198(2):112-8. PubMed ID: 20553828
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotective mechanisms of spironolactone associated with the angiotensin-converting enzyme/epidermal growth factor receptor/extracellular signal-regulated kinases, NAD(P)H oxidase/lectin-like oxidized low-density lipoprotein receptor-1, and Rho-kinase pathways in aldosterone/salt-induced hypertensive rats.
Nakano S; Kobayashi N; Yoshida K; Ohno T; Matsuoka H
Hypertens Res; 2005 Nov; 28(11):925-36. PubMed ID: 16555582
[TBL] [Abstract][Full Text] [Related]
12. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.
Stas S; Whaley-Connell A; Habibi J; Appesh L; Hayden MR; Karuparthi PR; Qazi M; Morris EM; Cooper SA; Link CD; Stump C; Hay M; Ferrario C; Sowers JR
Endocrinology; 2007 Aug; 148(8):3773-80. PubMed ID: 17494996
[TBL] [Abstract][Full Text] [Related]
13. Antioxidative effect of p38 mitogen-activated protein kinase inhibitor in the kidney of hypertensive rat.
Tojo A; Onozato ML; Kobayashi N; Goto A; Matsuoka H; Fujita T
J Hypertens; 2005 Jan; 23(1):165-74. PubMed ID: 15643139
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II receptor type 1-mediated vascular oxidative stress and proinflammatory gene expression in aldosterone-induced hypertension: the possible role of local renin-angiotensin system.
Hirono Y; Yoshimoto T; Suzuki N; Sugiyama T; Sakurada M; Takai S; Kobayashi N; Shichiri M; Hirata Y
Endocrinology; 2007 Apr; 148(4):1688-96. PubMed ID: 17218415
[TBL] [Abstract][Full Text] [Related]
15. Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker.
Nagase M; Shibata S; Yoshida S; Nagase T; Gotoda T; Fujita T
Hypertension; 2006 Jun; 47(6):1084-93. PubMed ID: 16636193
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin and mineralocorticoid receptor antagonism attenuates cardiac oxidative stress in angiotensin II-infused rats.
Minas JN; Thorwald MA; Conte D; Vázquez-Medina JP; Nishiyama A; Ortiz RM
Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1178-88. PubMed ID: 26234762
[TBL] [Abstract][Full Text] [Related]
17. Mineralocorticoid receptor blockade and calcium channel blockade have different renoprotective effects on glomerular and interstitial injury in rats.
Du J; Fan YY; Hitomi H; Kiyomoto H; Kimura S; Kong CZ; Noma T; Kohno M; Nishiyama A; Nakano D
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F802-8. PubMed ID: 19535572
[TBL] [Abstract][Full Text] [Related]
18. Paradoxical mineralocorticoid receptor activation and left ventricular diastolic dysfunction under high oxidative stress conditions.
Wang H; Shimosawa T; Matsui H; Kaneko T; Ogura S; Uetake Y; Takenaka K; Yatomi Y; Fujita T
J Hypertens; 2008 Jul; 26(7):1453-62. PubMed ID: 18551023
[TBL] [Abstract][Full Text] [Related]
19. Mineralocorticoid receptor blocker increases angiotensin-converting enzyme 2 activity in congestive heart failure patients.
Keidar S; Gamliel-Lazarovich A; Kaplan M; Pavlotzky E; Hamoud S; Hayek T; Karry R; Abassi Z
Circ Res; 2005 Oct; 97(9):946-53. PubMed ID: 16179584
[TBL] [Abstract][Full Text] [Related]
20. Effects of dietary salt on intrarenal angiotensin system, NAD(P)H oxidase, COX-2, MCP-1 and PAI-1 expressions and NF-kappaB activity in salt-sensitive and -resistant rat kidneys.
Chandramohan G; Bai Y; Norris K; Rodriguez-Iturbe B; Vaziri ND
Am J Nephrol; 2008; 28(1):158-67. PubMed ID: 17951998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
